Zamaneh Mikhak - 05 Jan 2023 Form 3 Insider Report for TFF Pharmaceuticals, Inc.

Role
Chief Medical Officer
Signature
/s/ Zamaneh Mikhak
Issuer symbol
N/A
Transactions as of
05 Jan 2023
Net transactions value
$0
Form type
3
Filing time
20 Jan 2023, 19:11:40 UTC
Next filing
13 Mar 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding TFFP Stock Option (Right to Buy) 05 Jan 2023 Common Stock 430,000 $0.9700 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Options shall vest and first become exercisable as follows: one quarter of the Options shall vest and first become exercisable on December 21, 2023, and the remainder of the Options shall vest and first become exercisable in 12 equal quarterly installments commencing on March 31, 2024.